2024-03-01 |
2024-02-29 |
PS
Planned sale
|
Doherty Catherine T.
EVP, Regional Businesses
Officer
|
1,187
-1.7%
125.88
149,420
USD
|
1,187
-1.7%
|
125.88
|
149,420
USD
|
|
2024-03-01 |
2024-02-29 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
5,611
-12.7%
125.88
706,313
USD
|
5,611
-12.7%
|
125.88
|
706,313
USD
|
|
2024-03-01 |
2024-02-28 |
PS
Planned sale
|
Doherty Catherine T.
EVP, Regional Businesses
Officer
|
5,557
-7.4%
126.57
703,349
USD
|
5,557
-7.4%
|
126.57
|
703,349
USD
|
|
2024-02-23 |
2024-02-23 |
S
Sale
|
Gregg Vicky B
Non-Executive Director
|
2,500
-13.3%
126.64
316,597
USD
|
2,500
-13.3%
|
126.64
|
316,597
USD
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Doherty Catherine T.
EVP, Regional Businesses
Officer
|
821
-1.1%
126.14
103,561
USD
|
821
-1.1%
|
126.14
|
103,561
USD
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
661
-1.6%
126.14
83,379
USD
|
661
-1.6%
|
126.14
|
83,379
USD
|
|
2023-03-08 |
2023-03-07 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Regional Businesses
Officer
|
5,307
-7.3%
140.55
745,899
USD
|
5,307
-7.3%
|
140.55
|
745,899
USD
|
|
2023-03-08 |
2023-03-07 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
4,754
-11.0%
140.55
668,175
USD
|
4,754
-11.0%
|
140.55
|
668,175
USD
|
|
2023-03-06 |
2023-03-03 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Regional Businesses
Officer
|
717
-1.0%
140.63
100,832
USD
|
717
-1.0%
|
140.63
|
100,832
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
593
-1.5%
138.54
82,154
USD
|
593
-1.5%
|
138.54
|
82,154
USD
|
|
2023-02-27 |
2023-02-24 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Regional Businesses
Officer
|
1,690
-2.4%
141.42
239,000
USD
|
1,690
-2.4%
|
141.42
|
239,000
USD
|
|
2023-02-27 |
2023-02-24 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
1,415
-3.5%
141.42
200,109
USD
|
1,415
-3.5%
|
141.42
|
200,109
USD
|
|
2022-12-05 |
2022-12-01 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
2,025
-7.7%
152.50
308,813
USD
|
2,025
-7.7%
|
152.50
|
308,813
USD
|
|
2022-11-29 |
2022-11-28 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Regional Businesses
Officer
|
23,407
-25.7%
149.37
3,496,390
USD
|
23,407
-25.7%
|
149.37
|
3,496,390
USD
|
|
2022-11-29 |
2022-11-28 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Regional Businesses
Officer
|
17,358
-16.0%
148.92
2,584,872
USD
|
17,358
-16.0%
|
148.92
|
2,584,872
USD
|
|
2022-11-02 |
2022-11-01 |
S
Sale
|
RING TIMOTHY M
Non-Executive Director
|
2,000
-7.6%
144.06
288,120
USD
|
2,000
-7.6%
|
144.06
|
288,120
USD
|
|
2022-10-27 |
2022-10-26 |
PS
Planned sale
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO
Officer
|
15,497
-32.6%
145.00
2,247,065
USD
|
15,497
-32.6%
|
145.00
|
2,247,065
USD
|
|
2022-10-04 |
2022-10-03 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
2,000
-7.7%
123.39
246,780
USD
|
2,000
-7.7%
|
123.39
|
246,780
USD
|
|
2022-09-06 |
2022-09-01 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
2,000
-7.7%
125.02
250,040
USD
|
2,000
-7.7%
|
125.02
|
250,040
USD
|
|
2022-08-02 |
2022-08-01 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
2,000
-7.7%
136.04
272,080
USD
|
2,000
-7.7%
|
136.04
|
272,080
USD
|
|
2022-07-05 |
2022-07-01 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
2,000
-7.7%
133.47
266,940
USD
|
2,000
-7.7%
|
133.47
|
266,940
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
900
-0.3%
142.13
127,921
USD
|
900
-0.3%
|
142.13
|
127,921
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
4,131
-1.2%
141.35
583,909
USD
|
4,131
-1.2%
|
141.35
|
583,909
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
9,823
-2.8%
140.58
1,380,927
USD
|
9,823
-2.8%
|
140.58
|
1,380,927
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
651
-0.2%
142.15
92,540
USD
|
651
-0.2%
|
142.15
|
92,540
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
2,565
-0.8%
141.36
362,591
USD
|
2,565
-0.8%
|
141.36
|
362,591
USD
|
|
2022-05-26 |
2022-05-25 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
6,821
-2.0%
140.60
959,046
USD
|
6,821
-2.0%
|
140.60
|
959,046
USD
|
|
2022-05-25 |
2022-05-24 |
S
Sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
156,282
-31.8%
140.12
21,898,546
USD
|
156,282
-31.8%
|
140.12
|
21,898,546
USD
|
|
2022-05-25 |
2022-05-24 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
126,126
-27.4%
140.12
17,672,775
USD
|
126,126
-27.4%
|
140.12
|
17,672,775
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
300
-0.1%
142.24
42,672
USD
|
300
-0.1%
|
142.24
|
42,672
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
1,000
-0.3%
141.51
141,509
USD
|
1,000
-0.3%
|
141.51
|
141,509
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
41,268
-10.9%
140.12
5,782,431
USD
|
41,268
-10.9%
|
140.12
|
5,782,431
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
200
-0.1%
142.26
28,451
USD
|
200
-0.1%
|
142.26
|
28,451
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
800
-0.2%
141.54
113,234
USD
|
800
-0.2%
|
141.54
|
113,234
USD
|
|
2022-05-25 |
2022-05-23 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
33,898
-9.2%
140.12
4,749,923
USD
|
33,898
-9.2%
|
140.12
|
4,749,923
USD
|
|
2022-05-19 |
2022-05-17 |
S
Sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
50,604
-56.3%
139.97
7,082,991
USD
|
50,604
-56.3%
|
139.97
|
7,082,991
USD
|
|
2022-03-09 |
2022-03-08 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
6,228
-13.7%
135.21
842,088
USD
|
6,228
-13.7%
|
135.21
|
842,088
USD
|
|
2022-03-09 |
2022-03-08 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
7,032
-9.4%
135.21
950,797
USD
|
7,032
-9.4%
|
135.21
|
950,797
USD
|
|
2022-03-02 |
2022-02-28 |
S
Sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
661
-1.7%
130.00
85,930
USD
|
661
-1.7%
|
130.00
|
85,930
USD
|
|
2022-02-28 |
2022-02-24 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
2,750
-4.1%
126.26
347,215
USD
|
2,750
-4.1%
|
126.26
|
347,215
USD
|
|
2022-02-28 |
2022-02-24 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
1,669
-4.3%
126.26
210,728
USD
|
1,669
-4.3%
|
126.26
|
210,728
USD
|
|
2021-12-01 |
2021-11-29 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
14,575
-17.5%
157.53
2,296,043
USD
|
14,575
-17.5%
|
157.53
|
2,296,043
USD
|
|
2021-12-01 |
2021-11-29 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
15,908
-16.0%
156.86
2,495,249
USD
|
15,908
-16.0%
|
156.86
|
2,495,249
USD
|
|
2021-12-01 |
2021-11-29 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
3,532
-3.4%
155.77
550,194
USD
|
3,532
-3.4%
|
155.77
|
550,194
USD
|
|
2021-12-01 |
2021-11-29 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
3,250
-3.1%
154.79
503,074
USD
|
3,250
-3.1%
|
154.79
|
503,074
USD
|
|
2021-12-01 |
2021-11-29 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
300
-0.3%
153.38
46,015
USD
|
300
-0.3%
|
153.38
|
46,015
USD
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
44,939
-52.8%
137.00
6,156,643
USD
|
44,939
-52.8%
|
137.00
|
6,156,643
USD
|
|
2021-03-11 |
2021-03-10 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
5,574
-12.2%
120.47
671,500
USD
|
5,574
-12.2%
|
120.47
|
671,500
USD
|
|
2021-03-01 |
2021-02-25 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
801
-2.0%
115.49
92,507
USD
|
801
-2.0%
|
115.49
|
92,507
USD
|
|
2021-02-25 |
2021-02-24 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
750
-1.8%
116.95
87,713
USD
|
750
-1.8%
|
116.95
|
87,713
USD
|
|
2021-02-25 |
2021-02-24 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
438
-1.0%
116.95
51,224
USD
|
438
-1.0%
|
116.95
|
51,224
USD
|
|
2020-12-28 |
2020-12-24 |
PS
Planned sale
|
GUINAN MARK
Executive Vice President & CFO
Officer
|
22,563
-23.5%
121.18
2,734,139
USD
|
22,563
-23.5%
|
121.18
|
2,734,139
USD
|
|
2020-12-28 |
2020-12-24 |
PS
Planned sale
|
GUINAN MARK
Executive Vice President & CFO
Officer
|
59,193
-38.1%
120.06
7,106,534
USD
|
59,193
-38.1%
|
120.06
|
7,106,534
USD
|
|
2020-11-27 |
2020-11-24 |
S
Sale
|
WILENSKY GAIL R
Non-Executive Director
|
6,111
-27.0%
126.02
770,120
USD
|
6,111
-27.0%
|
126.02
|
770,120
USD
|
|
2020-11-24 |
2020-11-23 |
PS
Planned sale
|
STANZIONE DANIEL
Non-Executive Director
|
2,300
-7.5%
127.45
293,137
USD
|
2,300
-7.5%
|
127.45
|
293,137
USD
|
|
2020-11-24 |
2020-11-23 |
PS
Planned sale
|
STANZIONE DANIEL
Non-Executive Director
|
3,302
-9.7%
126.46
417,584
USD
|
3,302
-9.7%
|
126.46
|
417,584
USD
|
|
2020-11-24 |
2020-11-23 |
PS
Planned sale
|
STANZIONE DANIEL
Non-Executive Director
|
5,621
-14.2%
125.73
706,738
USD
|
5,621
-14.2%
|
125.73
|
706,738
USD
|
|
2020-10-23 |
2020-10-21 |
S
Sale
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO
Officer
|
4,750
-15.9%
125.00
593,750
USD
|
4,750
-15.9%
|
125.00
|
593,750
USD
|
|
2020-10-23 |
2020-10-21 |
S
Sale
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO
Officer
|
5,700
-16.1%
125.00
712,500
USD
|
5,700
-16.1%
|
125.00
|
712,500
USD
|
|
2020-10-19 |
2020-10-16 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
291,997
-55.1%
120.00
35,039,640
USD
|
291,997
-55.1%
|
120.00
|
35,039,640
USD
|
|
2020-10-15 |
2020-10-14 |
S
Sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
35,591
-47.0%
119.00
4,235,329
USD
|
35,591
-47.0%
|
119.00
|
4,235,329
USD
|
|
2020-09-04 |
2020-09-02 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
3,776
-5.2%
111.13
419,616
USD
|
3,776
-5.2%
|
111.13
|
419,616
USD
|
|
2020-09-04 |
2020-09-02 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
54,616
-43.1%
110.57
6,038,727
USD
|
54,616
-43.1%
|
110.57
|
6,038,727
USD
|
|
2020-06-10 |
2020-06-08 |
PS
Planned sale
|
GUINAN MARK
Executive Vice President & CFO
Officer
|
8,524
-10.4%
118.60
1,010,980
USD
|
8,524
-10.4%
|
118.60
|
1,010,980
USD
|
|
2020-06-10 |
2020-06-08 |
PS
Planned sale
|
GUINAN MARK
Executive Vice President & CFO
Officer
|
18,246
-18.2%
117.65
2,146,624
USD
|
18,246
-18.2%
|
117.65
|
2,146,624
USD
|
|
2020-06-10 |
2020-06-08 |
PS
Planned sale
|
GUINAN MARK
Executive Vice President & CFO
Officer
|
45,826
-31.4%
116.81
5,352,981
USD
|
45,826
-31.4%
|
116.81
|
5,352,981
USD
|
|
2020-06-10 |
2020-06-08 |
PS
Planned sale
|
RING TIMOTHY M
Non-Executive Director
|
11,730
-36.4%
116.60
1,367,718
USD
|
11,730
-36.4%
|
116.60
|
1,367,718
USD
|
|
2020-04-28 |
2020-04-27 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President
Executive Director
|
11,717
-4.7%
112.01
1,312,433
USD
|
11,717
-4.7%
|
112.01
|
1,312,433
USD
|
|
2020-04-28 |
2020-04-27 |
PS
Planned sale
|
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
Officer
|
2,500
-10.0%
110.00
275,000
USD
|
2,500
-10.0%
|
110.00
|
275,000
USD
|
|
2020-04-28 |
2020-04-27 |
PS
Planned sale
|
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
Officer
|
2,500
-9.1%
112.03
280,075
USD
|
2,500
-9.1%
|
112.03
|
280,075
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
500
-1.3%
90.15
45,073
USD
|
500
-1.3%
|
90.15
|
45,073
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
421
-1.1%
88.53
37,269
USD
|
421
-1.1%
|
88.53
|
37,269
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
1,307
-3.2%
87.81
114,772
USD
|
1,307
-3.2%
|
87.81
|
114,772
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
1,085
-2.6%
86.65
94,020
USD
|
1,085
-2.6%
|
86.65
|
94,020
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
200
-0.5%
85.59
17,118
USD
|
200
-0.5%
|
85.59
|
17,118
USD
|
|